SCHEMBL5705204

SCHEMBL5705204

CN1Cc2ccccc2N(Br)C1=O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
CREBBP Q92793 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
NOTUM Q6P988 2/20 0.35
HSD17B3 P37058 1/20 0.35
PARP1 P09874 1/20 0.35
HRH1 P35367 2/20 0.35
SLC6A4 P31645 1/20 0.35
MAOA P21397 2/20 0.34
MAOB P27338 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PLA2G7 Q13093 1/20 0.34
HTT P42858 1/20 0.34
LMNA P02545 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3525035 0.81 BRD4 (0.47) BRD4CREBBPSMN1; SMN2ALDH1A1HPGD
SCHEMBL28354783 0.78 AADAT (0.38) SMN1; SMN2ALDH1A1HPGDNOTUMHSD17B3
SCHEMBL18034998 0.75
SCHEMBL13015326 0.75 BRD4 (0.42) BRD4CREBBPSMN1; SMN2ALDH1A1HPGD
SCHEMBL6362811 0.75 HRH1 (0.42) BRD4CREBBPSMN1; SMN2ALDH1A1HRH1
SCHEMBL6362104 0.75 HPGD (0.54) BRD4CREBBPALDH1A1HPGDSLC6A4
SCHEMBL30642159 0.70 HPGD (0.57) HPGDNOTUMKMT2ATDP1
SCHEMBL1464486 0.70 HPGD (0.57) HPGDNOTUMKMT2ATDP1
SCHEMBL28358498 0.69 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1NOTUM
SCHEMBL31033151 0.68 ALDH1A1 (0.56) ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708713-A1 1-BENZYL-5-PIPERAZIN-1-YL-3,4 DIHYDRO-1H-QUINAZOLIN-2-ONE DERIVATIVES AND THE RESPECTIVE 1H-BENZO(1,2,6)THIADIAZINE-2,2-DIOXIDE AND 1,4-DIHYDRO-BENZO(D)(1,3)OXAZIN-2-ONE DERIVATIVES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT) FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM F. Hoffman-la Roche AG (CH) 2006-10-11 EP disclosed
WO-2005067933-A1 1-BENZYL-5-PIPERAZIN-1-YL-3,4 DIHYDRO-1H-QUINAZOLIN-2-ONE DERIVATIVES AND THE RESPECTIVE 1H-BENZO(1,2,6)THIADIAZINE-2,2-DIOXIDE AND 1,4-DIHYDRO-BENZO(D) (1,3)OXAZIN-2-ONE DERIVATIVES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT) FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM F. HOFFMANN-LA ROCHE AG (CH) 2005-07-28 WO disclosed